Clinical Trial Update: The Clinical Study of the Efficacy and Safety of Trop2-ADC Monotherapy or Combination Immunotherapy Strategy in the Treatment of Advanced Triple-negative Breast Cancer. [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating Trop2-ADC as monotherapy or in combination with immunotherapy for metastatic triple-negative breast cancer. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Trop2 ADC

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Metastatic Triple-negative Breast Cancer | Phase 2 | Status: RECRUITING